Genetic Signatures Limited announced that it received the CE-IVD registration for its SARS-CoV-2 Detection Kit overnight. The application was submitted late last week as detailed in the Company's announcement dated on 30 March 2020 and allows the kit to be marketed freely in the European Union. As previously advised, Genetic Signatures has already shipped kits to Europe, and this will clear the way for supply contracts with new larger European customers. Negotiations are underway with potential customers in Germany, UK and Spain. An application for TGA registration was also lodged at the same time, and this clearance is anticipated in the coming weeks. The new SARS-CoV-2 Detection Kit can be used on Genetic Signatures higher throughput instrument, GS-1000, which has the ability to process approximately 1,500 samples in a 24-hour period in a fully staffed laboratory in batches of 188 samples per run.